Agilent Technologies, Inc.
A Healthcare Diagnostics & Research
Agilent Technologies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $6.9 billion, up 6.73% from fiscal 2024. In the quarter to July 2026, revenue grew 8.06%, EPS grew 8.47%, free cash flow grew 69.5% and total debt rose 8.81%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.
Follow A
Agilent Technologies, Inc. (A) Revenue growth
Agilent Technologies, Inc.'s revenue growth over the twelve months to 31 July 2026 was 8.60%, up 1.9 percentage points from fiscal 2025 (6.73%). Over the past ten years it has ranged from −4.73% (fiscal 2024) to 18.4% (fiscal 2021); the current reading is higher than 73% of that period. That is above the Diagnostics & Research industry median of 7.69% and in line with the Healthcare sector median of 8.27%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 6.73% | 11.46 |
| FY2024 | −4.73% | (4.51) |
| FY2023 | −0.22% | (8.59) |
| FY2022 | 8.37% | (9.99) |
| FY2021 | 18.4% | 14.95 |
| FY2020 | 3.41% | (1.66) |
| FY2019 | 5.07% | (4.81) |
| FY2018 | 9.88% | 3.45 |
| FY2017 | 6.43% | 2.37 |
| FY2016 | 4.06% | 4.31 |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Jul 2026 | 8.06% | (1.95) |
| Apr 2026 | 10.0% | 3.05 |
| Jan 2026 | 6.96% | (2.45) |
| Oct 2025 | 9.41% | (0.73) |
| 43 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| WAT Waters Corporation compare | 52.5% |
| NTRA Natera, Inc. compare | 37.8% |
| IDXX IDEXX Laboratories, Inc. compare | 12.8% |
| DGX Quest Diagnostics Incorporated compare | 9.87% |
| A Agilent Technologies, Inc. | 8.60% |
| IQV IQVIA Holdings Inc. compare | 8.17% |
| MTD Mettler-Toledo International, Inc. compare | 6.91% |
| LH Labcorp Holdings Inc. compare | 6.41% |
| ILMN Illumina, Inc. compare | 4.88% |
| Diagnostics & Research industry median | 7.69% |
| Healthcare sector median | 8.27% |
| Market median | 7.41% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on A
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement